These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38025540)

  • 1. Analysis of the clinical characteristics and prognosis of adult
    Sheng L; Liu Y; Zhu Y; Zhou J; Hua H
    Open Med (Wars); 2023; 18(1):20230830. PubMed ID: 38025540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristic Analysis of Adult Acute Myeloid Leukemia Patients with
    Sheng L; Liu YJ; Zhou JF; Chao HY; Hua HY; Zhou X; Zhao XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1063-1070. PubMed ID: 39192399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPN11 mutations in adult acute myeloid leukaemia: Prevalence and clinical implications in the context of NPM1 mutation.
    Liu J; Qin W; Wang B; Wang Z; Hua H; Zhou F; Jia Z; Wu P; Chao H; Lu X
    Leuk Res; 2022 Jul; 118():106859. PubMed ID: 35617714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia.
    Chen X; Tian C; Hao Z; Pan L; Hong M; Wei W; Muyey DM; Wang H; Chen X
    Cancer Med; 2023 May; 12(9):10340-10350. PubMed ID: 36912186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Mutated Gene Sequenced by NGS and the Correlation of Their Coexistent Mutual Exclusiveness in NPM1 Mutated Acute Myeloid Leukemia].
    Dai L; Wang ZL; Qiu GQ; Wu YC; Zhang XW; Xing SS; Wang B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1733-1740. PubMed ID: 34893102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical influences of
    Yang X; Shi J; Zhang X; Zhang G; Zhang J; Yang S; Wang J; Ke X; Fu L
    Cancer Manag Res; 2018; 10():2489-2497. PubMed ID: 30122998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRAS
    Pan L; Liang F; Chen X; Hao Z; Muyey DM; Chen X; Wang H
    Ann Clin Lab Sci; 2023 May; 53(3):389-397. PubMed ID: 37437942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and prognostic analysis of acute myeloid leukemia patients with PTPN11 mutations.
    Sun Y; Zhang F; Huo L; Cai W; Wang Q; Wen L; Yan L; Shen H; Xu X; Chen S
    Hematology; 2022 Dec; 27(1):1184-1190. PubMed ID: 36318614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of Next Generation Sequencing Based Genotypic Profiling with MICM Characteristics in NPM1 Mutated Acute Myeloid Leukemia].
    Wang B; Ling Y; Dai L; Gu WY; Zhang XW; Xing SS; Li HQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):56-60. PubMed ID: 35123604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.
    Yang J; Zhao L; Wu Y; Niu T; Gong Y; Chen X; Huang X; Liu J; Dai Y; Ma H
    Cancer Med; 2023 Dec; 12(23):21111-21117. PubMed ID: 37937729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of Coexisting Gene with NRAS in Acute Myeloid Leukemia].
    Sheng YP; Hua HY; Chao HY; Zhu WY; Wang ZQ; Zhang Y; Zhou Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):351-356. PubMed ID: 35395962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia.
    Alfayez M; Issa GC; Patel KP; Wang F; Wang X; Short NJ; Cortes JE; Kadia T; Ravandi F; Pierce S; Assi R; Garcia-Manero G; DiNardo CD; Daver N; Pemmaraju N; Kantarjian H; Borthakur G
    Leukemia; 2021 Mar; 35(3):691-700. PubMed ID: 32561839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and prognostic significance of DNMT3A, FLT3, and NPM1 mutations in de novo acute myeloid leukemia patients.
    Chen M; Zeng Z; Li X; Qin W; Cai X; Chen S; Lu X
    Int J Lab Hematol; 2023 Dec; 45(6):899-907. PubMed ID: 37519024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
    Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
    Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia.
    Strickland SA; Shaver AC; Byrne M; Daber RD; Ferrell PB; Head DR; Mohan SR; Mosse CA; Moyo TK; Stricker TP; Vnencak-Jones C; Savona MR; Seegmiller AC
    Leuk Res; 2018 Feb; 65():67-73. PubMed ID: 29310020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation of next-generation sequencing-based genotypic profiles with clinicopathologic characteristics in NPM1-mutated acute myeloid leukemia.
    Wang B; Yang B; Wu W; Liu X; Li H
    BMC Cancer; 2021 Jul; 21(1):788. PubMed ID: 34238278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.
    Ahn JS; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):61-70. PubMed ID: 26234722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.
    Xu Y; Sun Y; Shen H; Ding L; Yang Z; Qiu H; Sun A; Chen S; Wu D
    Am J Hematol; 2015 Nov; 90(11):992-7. PubMed ID: 26223865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns.
    Guan W; Zhou L; Li Y; Yang E; Liu Y; Lv N; Fu L; Ding Y; Wang N; Fang N; Liu Q; Wang B; Li F; Zhang J; Wang M; Wang L; Jing Y; Li Y; Yu L
    Exp Hematol Oncol; 2021 Apr; 10(1):27. PubMed ID: 33836835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid sarcoma with
    Ramia de Cap M; Wu LP; Hirt C; Pihan GA; Patel SS; Tam W; Bueso-Ramos CE; Kanagal-Shamanna R; Raess PW; Siddon A; Narayanan D; Morgan EA; Pinkus GS; Mason EF; Hsi ED; Rogers HJ; Toth L; Foucar K; Hurwitz SN; Bagg A; Rets A; George TI; Orazi A; Arber DA; Hasserjian RP; Weinberg OK;
    Leuk Lymphoma; 2023 May; 64(5):972-980. PubMed ID: 36960680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.